IL6 and Miyoshi myopathy: Our study showed significant differences in IL-6 levels across disease stages (p < 0.05) and a clear positive correlation with DS staging (r = 0.6347, p < 0.0001), suggesting that IL-6 levels rise more markedly during MM progression.